NCT01222338: Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients |
|
|
| Completed | 2 | 123 | RoW | V-5 immunitor, V5, V-5 immunitor | Lisichansk Regional Tuberculosis Dispensary, National Medical University, Ukraine, Immunitor USA Inc. | Tuberculosis | 12/10 | 01/11 | | |
